论文部分内容阅读
目的:探讨中药口服与熏蒸联合匹多莫德治疗小儿反复呼吸道感染的免疫学(CD3+,CD4+,CD8+IgG和IgA水平)疗效分析。方法:收集来我院就诊的小儿反复呼吸道感染患者220例,随机分为试验组和对照组,观察两组患者在免疫学上的疗效差异。结果:治疗后两组患者免疫学水平改善程度试验组均优于对照组,且试验组治疗有效率高于对照组,差异均有统计学意义(P<0.05)。结论:中药口服与熏蒸联合匹多莫德治疗可显著提高小儿反复呼吸道感染患者的免疫力,减轻临床症状,疗效显著。
Objective: To investigate the efficacy of oral and fumigation combined with pidotimod in the treatment of children with recurrent respiratory tract infections (CD3 +, CD4 +, CD8 + IgG and IgA levels). Methods: A total of 220 children with recurrent respiratory tract infection in our hospital were collected and randomly divided into experimental group and control group. The immunological effects of the two groups were observed. Results: After treatment, the improvement of immunological level in both groups was better than that in the control group, and the treatment efficiency in the experimental group was higher than that in the control group (P <0.05). Conclusion: The combination of traditional Chinese medicine and fumigation in combination with pidotimod can significantly improve the immunity of children with recurrent respiratory tract infections, relieve clinical symptoms and have a significant therapeutic effect.